CFDB - Cystic Fibrosis DataBase

ongoing trials trial from

SGLT2 Inhibitor Therapy in Cystic Fibrosis-related Diabetes - Phase 2|Phase 3 - Not yet recruiting

Study design (if review, criteria of inclusion for studies)

Interventional - Allocation: Randomized|Intervention Model: Crossover Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment


Cystic Fibrosis-related Diabetes|Cystic Fibrosis - 18 Years and older   (Adult, Older Adult)


Drug: Empagliflozin|Other: Placebo Control

Outcome measures

Feasibility, safety, tolerability

Keywords: Empagliflozin; SGLT2 inhibitors; Hypoglycemic Agents; pharmacological_intervention;